CLOROX CO annual report, FY2025

Full document

Business Context and Reporting Period

Company: The Clorox Company (CLX)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended June 30, 2025
Business Overview: A leading multinational manufacturer of consumer and professional products with operations in approximately 25 countries. Key brands include Clorox, Pine-Sol, Glad, Fresh Step, Hidden Valley, Brita, and Burt's Bees. The company operates under the "IGNITE" strategy to drive innovation and profitability.

Key Financial Metrics

  • Net Sales: $7.1 billion for fiscal year 2025 (essentially flat year-over-year).
  • Diluted EPS: Increased 190% compared to the prior year.
  • Dividends: $602 million paid to shareholders during fiscal 2025; a 2% dividend increase was announced in July 2025.
  • Debt: Approximately $2.5 billion as of June 30, 2025.
  • Market Capitalization: Approximately $19.9 billion (as of December 31, 2024).
  • Employees: Approximately 7,600 worldwide as of June 30, 2025.
  • Customer Concentration: Walmart accounts for 27% of consolidated net sales; the top five customers account for nearly 50%.

Material Changes vs. Prior Period

  • EPS Growth Drivers: The 190% EPS increase was primarily driven by one-time losses in the prior year (Argentina divestiture and pension settlement charge) and benefits in the current year (higher volume, cost savings, and cyberattack insurance recoveries).
  • Divestitures: Completed the sale of the Better Health Vitamins, Minerals, and Supplements (VMS) business in September 2024, resulting in a recorded loss. Previously divested the Argentina business in March 2024.
  • Joint Venture Wind-Down: Announced in February 2025 that the venture agreement with Procter & Gamble for the Glad business will terminate on January 31, 2026. Clorox will acquire P&G's 20% interest at fair market value (estimated at $476 million as of June 30, 2025).
  • Operational Headwinds: The back half of the fiscal year saw temporary category slowdowns and lower sales due to heightened macroeconomic uncertainties and changes in consumer shopping behaviors.
  • ERP Implementation: Incremental shipments in Q4 2025 provided a sales benefit as retailers stocked up ahead of the U.S. ERP transition; this impact is expected to reverse in fiscal 2026.

Outlook, Risks, and Management Commentary

  • Strategic Focus: Management remains focused on the IGNITE strategy, investing in brands, digital capabilities, and a streamlined operating model. The company expects to continue investing in transformative technologies, including a new ERP system, with total incremental investment expected between $570 million and $580 million.
  • Cybersecurity: The company has fully recovered from the August 2023 cyberattack but notes that operational disruption risks remain. Cybersecurity insurance recoveries contributed to current period earnings.
  • Key Risks:
    • Macroeconomic Conditions: Inflation, tariffs, and geopolitical instability (Ukraine, Middle East, China) could impact raw material costs and consumer demand.
    • Competition: Intense competition from private label brands and alternative retail channels (e-commerce, discounters).
    • Supply Chain: Exposure to commodity price volatility and potential supply disruptions.
    • Regulatory: Changes in tax laws (including the "One Big Beautiful Bill Act" enacted July 4, 2025) and environmental regulations.
  • Contingencies: Recorded environmental liabilities of $27 million as of June 30, 2025. The company faces potential litigation regarding product liability and advertising claims.

Investor Verification Checklist

  • Verify the sustainability of the 190% EPS growth, noting it is heavily influenced by non-recurring prior-year charges and current-year insurance recoveries.
  • Monitor the impact of the ERP system implementation in fiscal 2026, specifically the expected reversal of Q4 2025 inventory build-up benefits.
  • Assess the financial impact of acquiring P&G's 20% interest in the Glad business upon the venture's termination in January 2026.
  • Review the company's ability to maintain margins amidst rising raw material costs and potential tariff increases.
  • Confirm the status of the "One Big Beautiful Bill Act" impact on the company's effective tax rate and consolidated financial statements.